However, although the number of somatic mutations was numerically higher in mutant TP53 samples compared to wild-type TP53 samples in each of the breast cancer subtypes, the results were statistically significant only luminal B samples (p = 0.008, Fig. 1a). This evidence concerns the gene TP53 and breast cancer.